Manufacturing News of Note—Samsung Bioepis, Biogen add to biosimilars; Boehringer Ingelheim to add 105 jobs in Puerto Rico

stocks
(Pixabay)

> Biogen and Samsung Bioepis are expanding their biosimilar agreement. Story

> Croatia has taken action against NCPC Hebei Huamin Pharmaceutical over manufacturing issues. EMA

> Boehringer Ingelheim’s animal health unit will invest nearly $50 million to expand a plant in Puerto Rico and expects to add 105 jobs. Release

Whitepaper

Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

> Chinese biotech Akeso Pharmaceuticals will open a new GE flex facility in Guangzhou, China. Release 

Suggested Articles

Fujifilm has completed the first manufacturing facility in Japan to make drug-delivering liposomes to use for cancer fighting drugs it is developing.

Three Samsung execs face up to two years in jail for their roles in destroying data and documents at under-fire affiliate Samsung BioLogics.

The FDA has slapped a U.S. drug repackager, saying in a warning letter that its storage processes and equipment cleaning are not up to expectations.